info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Europe, the Middle East and Africa Blood Glucose Test Strip Packaging Market– Forecast to 2032


ID: MRFR/MED/0158-HCR | 70 Pages | Author: Kinjoll Dey| December 2024

Europe, the Middle East, and Africa Blood Glucose Test Strip Packaging Market Overview


Europe, the Middle East and Africa Blood Glucose Test Strip Packaging Market Size was valued at USD 0.98 Billion in 2023. The Global Europe, the Middle East and Africa Blood Glucose Test Strip Packaging industry is projected to grow from USD 1.03 Billion in 2024 to USD 1.83 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.56% during the forecast period (2024 - 2032).


One of the greatest methods to comprehend diabetes and how different meals, drugs, and activities impact diabetes is to test your blood sugar levels. Monitoring the blood sugar level can assist a doctor in creating a plan of care for this illness. Using a glucose meter, blood glucose monitoring measures the blood's level of glucose. Typically, a fingerstick is used to puncture the skin to get blood for a blood glucose test, which is crucial for managing diabetes. The blood is then deposited on a disposable "test strip" that has been chemically charged. The main option is continuous glucose monitoring (CGM). Most devices monitor a power characteristic and use this information to compute the blood flow, even if different manufacturers use different methods.


The rise of the blood glucose test strip market in Europe is driven by the rising prevalence of diabetes amongst the continent's population. The International Diabetes Federation estimates that 61 million persons in Europe will have diabetes in 2021. A person's diagnosis of diabetes is influenced by several important factors, including genetic problems, lifestyle modifications, rising consumption of junk food and sugary foods, alcohol consumption, and others, as well as lifestyle changes like these. Due to the surge in the number of diabetes patients, blood glucose test strip is being used more frequently. All age groups have shown an increase in diabetes incidence in recent years. Due to the increasing use of diabetic-related equipment that depends on those sugar test strips to do the tests and generate the results, the market for these products has grown.


In the Middle East and Africa, self-monitoring with a glucometer is more popular due to the high costs involved with continuous glucose monitoring. These tools aid in the early recognition of hypo- and hyperglycemia situations, frequently driving the glucose monitoring industry. When buying blood glucose test strips, cost is frequently a major consideration. Although many nations reimburse patients for prescription test strips, most patients still must shell out money for them through their financial resources. Over the past ten years, there has been an increase in the prevalence of diabetic patients in Africa.


EME and Africa Blood Glucose Test Strip Packaging Market Trends


CGMs To Take Over Majority Stake Globally


Compared to the typical routine of checking blood glucose levels at predetermined intervals, CGMs provide a more descriptive view of blood glucose trends and patterns. The available CGM systems can either download data and retroactively display blood glucose trend information or provide receiver displays with real-time glucose information. To help with timely blood glucose management, most real-time CGMs may inform patients, parents, or carers during actual or impending hyperglycemia visits. In emerging nations, the prevalence of lifestyle disorders like diabetes is rising, driving up blood glucose monitoring equipment sales. The greater knowledge of hospitals and preventive care is also aiding the market's expansion. Self-monitoring blood glucose has become more popular among patients.


Aging Populations


The aging population in Europe is projected to help fuel the expansion of the blood glucose test strip packaging market there. In Europe, between the ages of 60 and 79, almost 20 million individuals have been diagnosed with diabetes, and the number of sick people is steadily rising. To prevent dangerous circumstances in their daily lives, people need to check glucose levels in their bodies regularly. Diabetes prevalence is correlated with a rise in many chronic conditions, including cardiovascular disease and chronic wounds. As a result, older adults have started using blood glucose test kits more frequently lately.


Europe, the Middle East, and Africa Blood Glucose Test Strip Packaging Market Regional Insights


Due to the rising use of flexible packaging options, new product launches, and R&D among the top key Players, Europe's blood glucose test strip packaging sector has the second-largest market share. Additionally, the highest market share was held by the German Blood Glucose Test Strip Packaging market. The European Region's fastest-growing market was the Blood Glucose Test Strip Packaging market in the United Kingdom. Germany accounted for Europe's largest share of the market.


According to the German Diabetes Center, the overall prevalence of diabetes in Germany is currently estimated to be 7.2%, with a sharp increase expected over the next 20 years. Germany's adult population has an exceptionally high rate of both type 1 & type 2 diabetes, along with many people who have not yet been diagnosed. It is projected that the number of cases of type 2 diabetes will dramatically increase during the upcoming years due to aging populations and unhealthy lifestyles. The number of persons with diabetes will significantly rise during the next 20 years. Twelve million individuals in Germany could get type 2 diabetes in the next twenty years.


Europe, the Middle East, and Africa Blood Glucose Test Strip Packaging Key Market Players & Competitive Insights


The European market is expected to grow slowly over the projected period due to poor blood glucose monitoring device awareness among the people in Europe and unfavorable reimbursement rules. Self-monitoring strip mistakes are yet another factor impeding market expansion. Reluctance toward the product is caused by the fact that these strips need a small amount of blood to produce findings on blood glucose monitoring gadgets that may seem slightly unpleasant. One of the primary business strategies manufacturers use in the Blood Glucose Test Strip Packaging business to benefit customers and expand the market sector is local manufacturing to reduce operational costs. The Blood Glucose Test Strip Packaging sector has recently provided some of the most important medical benefits.


Key Companies in Europe, the Middle East, and Africa Blood Glucose Test Strip Packaging Market Include



  • CSP Technologies (US),

  • Sanner (US),

  • Multisorb Technologies (U.S),

  • Arkray

  • Ascensia Diabetes Care

  • Bionime Corporation

  • Trivida

  • Rossmax

  • Impak Corporation (U.S),

  • Laminated Films & Packaging (LF&P),

  • INC (US),

  • Flow Dry Technology, INC. (US),

  • Abbott

  • Hoffmann-La Roche AG

  • Johnson & Johnson

  • Dexcom

  • Medtronic

  • LPS Industries, LLC (US)

Report Attribute/Metric Details
Market Size USD 1.83 Million by 2032
CAGR   4.56% (2024-2032)
Base Year   2021
Forecast Period   2024-2032
Historical Data   2020
Forecast Units   Value (USD Million)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Types, end user, Region
Geographies Covered Europe, Middle East and Africa
Key Vendors CSP Technologies (US), Sanner (US), Multisorb Technologies (U.S), Arkray Ascensia Diabetes Care, Bionime Corporation, Trivida, Rossmax, Impak Corporation (U.S), Laminated Films & Packaging (LF&P), INC (US), Flow Dry Technology, INC. (US), Abbott Hoffmann-La Roche AG, Johnson & Johnson, Dexcom, Medtronic, LPS Industries, LLC (US)


Leading companies partner with us for data-driven Insights.

client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.